肝脾动脉联合栓塞治疗原发性肝癌合并脾功能亢进的临床观察  

Clinical Observation of TACE Combined with PSE Treating Hepatocellular Carcinoma with Hypersplenism

作　　者：郭秀英[1] 郭志[1] 刘方[1] 张俊义[1] 邢纪中[1] 

机构地区：[1]天津医科大学附属肿瘤医院介入科,天津市300060

出　　处：《中国肿瘤临床》2004年第17期980-982,共3页Chinese Journal of Clinical Oncology

摘　　要：目的:观察肝脾动脉联合栓塞治疗原发性肝癌合并脾功能亢进的疗效与安全性。方法:采用肝动脉化疗栓塞术(TACE)联合部分脾栓塞(PSE)治疗并发肝硬化、门脉高压和脾功能亢进的原发性肝癌患者30例,观察术后瘤体缩小程度和脾功能亢进缓解情况。结果:肝癌瘤体缩小有效率达73.33%;28例脾功能亢进缓解,有效率达93.33%。未发生脾脓肿等严重并发症。结论:TACE联合PSE是治疗原发性肝癌并发肝硬化、门脉高压和脾功能亢进安全、有效的方法。Objective: To observe the effectiveness and safety of transcatheter arterial chemoembolization (TACE) combined with partial splenic embolization (PSE) treating primary hepatocelluar carcinomar (HCC) with hypersplenism. Methods: Thirty patients with liver cirrhosis,portal hypertension and hypersplenism were treated by TACE and PSE to observe the degree for reduction of tumor volume and remission of hypersplenism. Results: Tumor reduction rate of HCC patients was 73.33%. The emission rate in 28 hypersplenism patients was 93.33% and there was no severe complication such as hepatic abscess. Conclusion: TACE combined with PSE is a safe and effective method to treat HCC with liver cirrhosis, portal hypertension and hypersplenism.

关 键 词：原发性肝癌 肝动脉栓塞 部分脾栓塞 脾功能亢进 

分 类 号：R735.7[医药卫生—肿瘤] R815[医药卫生—临床医学]